Upcoming events
Swiss Biotech Day 2024
In person
On April 22 – 23, ZoBio will participate in the Swiss Biotech Day in Basel. As a premier conference in Europe, the event serves as a vital platform for professionals to convene, fostering networking opportunities and facilitating discussions on the latest developments in R&D, manufacturing, data management, artificial intelligence, and innovative financing.
International biotech delegations use the “Global Village” to strengthen their ties with Switzerland as a biotech hub and promote cross-border investments, public-private partnerships, research and development collaborations and exchange of talent.
Through direct interaction with decision makers, Jan Schultz, Managing Director Business Development will effectively communicate recent developments within ZoBio and provide updates on ongoing activities to key industry leaders.
Past events
EFMC-ACSMEDI Medicinal Chemistry Frontiers 2024
In person
From 8 to 11 April Johan Veerman and Gregg Siegal attended ACSMEDI-EFMC Medicinal Chemistry Frontiers symposium. The EFMC | ACSMEDI Medicinal Chemistry Frontiers is co-organized as a collaboration between the EFMC, European Federation for Medicinal Chemistry and Chemical Biology, and ACS MEDI, the division of Medicinal Chemistry of the American Chemical Society. The 2024 edition took place in Utrecht, NL, together with the Section for Medicinal Chemistry and Chemical Biology of KNCV.
The meeting attracted a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
On Tuesday, April 9th Johan Veerman had an opportunity to present the lecture: The Art of Crafting a Mode of Action: Site Selective Hit Discovery.
Drug Discovery Chemistry
In person
Every year ZoBio is actively participating in the Drug Discovery Chemistry event hosted by the Cambridge Healthtech Institute. This event serves as a premier gathering for medicinal chemists in the pharmaceutical and biotech industries, focusing on the challenges and advancements in small molecule drug discovery and optimization.
This year Johan Veerman presented Site Directed Hit Discovery to Define the Mode of Action during the Fragment-Based Drug Discovery session on Tuesday, April 2nd. He highlighted ZoBio’s proficiency in fragment-based drug discovery strategies.
Two days later Gregg Siegal’s lecture Biophysical Approaches to Molecular Glue Discovery showed ZoBio’s innovative strategies and methodologies employed in molecular glue discovery, showcasing the company’s expertise and capabilities in this specialized area of drug discovery.
During the entire conference the ZoBio team was present at the booth # 500 answering all the questions about the company services.
BIO-Europe Spring
In person
From March 18 to 20, ZoBio participated in BIO- Europe Spring in Barcelona. With over 3,700 biotechnology and pharma leaders in attendance, it’s a prime venue to establish new partnerships and explore potential business opportunities.
Jan Schultz, Managing Director of Business Development, actively participated in One-on-One meetings. These meetings provided a valuable opportunity for direct engagement with potential partners, allowing ZoBio to tailor its pitch and discussions to each individual’s interests and needs.
BIO-Europe Spring is an excellent platform for ZoBio to network, exchange ideas, and potentially forge valuable partnerships that could drive future growth and innovation.